According to the new market research report "Radiotherapy Market by Type (External (IGRT,
IMRT, 3D-CRT, Stereotactic), Brachytherapy (LDR, HDR)), Product (LINAC, CyberKnife, Gamma
Knife, Tomotherapy, Particle Therapy, Cyclotron), Application (Prostate, Breast), End User
(Hospital) - Forecasts to 2024", is projected to reach USD 7.0 billion by 2024 from USD 5.6
billion in 2018, at a CAGR of 4.1%
Don't miss out on business opportunities in Radiotherapy Market.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=567
Technological advancements in radiotherapy and the rising incidence of cancer are the major
factors driving the growth of this market. Additionally, the growing adoption of radiotherapy
procedures for cancer treatment, increasing use of particle therapy for cancer treatment, and
the rising number of conferences and symposia focusing on the advancements in radiotherapy
are some of the other major factors driving the growth of this market.
The prostate cancer segment is expected to account for the second-largest share of the
external beam radiotherapy market, by application, in 2018
Based on application, the external beam radiotherapy market is segmented into prostate
cancer, breast cancer, lung cancer, head & neck cancer, colorectal cancer, and other cancers.
The prostate cancer segment is expected to account for the second-largest share of the